Triochem Products Ltd.

BSE: TRIPR512101ISIN INE331E01013

Healthcare
Pharmaceuticals

Share price

—

52W high: —
52W low: —
Off 52W high: —
1M return: —
3M return: —
6M return: —
1Y return: —
20D avg volume: —
50 DMA: —
200 DMA: —

Key ratios Standalone

Market cap: ₹0.43 Cr
Current price: —
52W high / low: — / —
Face value: ₹10.00
P/E: 0.05
P/B: 0.03
EPS (TTM): ₹330.45
Book value / share: ₹638.80
ROE: 51.73%
ROCE: 50.80%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-11.73 Cr
Interest cover: 132.50
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.17	0.13	0.22	0.30	0.22	0.32	—
	0.04	0.30	0.39	0.44	0.37	0.35	—
	0.00	0.00	0.00	0.00	0.00	0.05	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.01	0.11	0.14	0.14	0.14	0.15	—
	0.00	0.08	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.01	0.02	0.02	0.02	—
	0.03	0.11	0.24	0.29	0.22	0.13	—
	0.12	-0.18	-0.17	-0.15	-0.15	-0.03	—
	0.00	11.17	0.00	0.00	0.00	0.00	—
	0.12	10.99	-0.17	-0.15	-0.15	-0.03	—
	0.03	2.66	-0.04	0.05	-0.12	0.42	—
	0.09	8.33	-0.13	-0.19	-0.03	-0.45	—
	3.87	339.83	-5.38	-7.86	-1.25	-18.44	—
Key metrics
	0.12	11.07	-0.16	-0.13	-0.13	-0.01	—
	—	53.10%	—	-1.10%	—	-0.20%	—
	400.00%	1,951.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.00	0.00	0.00	—
	0.82	0.86	1.05	—
	1.17	1.51	1.30	—
	0.00	0.00	0.05	—
	0.00	0.00	0.00	—
	0.40	0.53	0.59	—
	0.08	0.08	0.00	—
	0.03	0.05	0.08	—
	0.67	0.86	0.58	—
	-0.38	-0.65	-0.25	—
	11.17	11.17	0.00	—
	10.79	10.52	-0.25	—
	2.70	2.55	0.15	—
	8.10	7.97	-0.40	—
	330.46	325.34	-16.33	—
Key metrics
	10.90	10.65	-0.17	—
	—	50.80%	-1.80%	—
	—	2,092.50%	—	—
	—	-2.87	0.20	—
	—	-0.36	-0.50	—
	—	0.00	0.00	—
	—	-11.73	-0.91	—
Balance sheet
	—	20.88	13.89	—
	—	12.99	2.52	—
	—	11.73	0.91	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	1.25	1.45	—
	—	0.00	0.54	—
	—	0.03	0.15	—
	—	0.03	0.22	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	20.65	13.67	—
Cash flow
	—	-2.87	0.20	—
	—	13.70	0.17	—
	—	0.00	0.00	—
	—	0.00	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 68.64%

Holder	Type	Holding	Previous	Change
GRACE R DEORA	Promoter	14.69%	—	—
RAJESH RAMU DEORA	Promoter	14.69%	—	—
RAMU SITARAM DEORA	Promoter	14.08%	—	—
RAJIV RAMU DEORA	Promoter	13.99%	—	—
RAMU MAHABIRPRASAD DEORA HUF	Promoter	11.19%	—	—
TRIOCHEM LABORATORIES PRIVATE LIMITED	Public	4.90%	—	—
AMBERNATH PLASTO PACKAGING PRIVATE LIMITED	Public	4.90%	—	—
G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED	Public	4.90%	—	—
PRAVINA NAKUM	Public	2.94%	—	—
MITAL SHRIKANT THAKKER	Public	2.86%	—	—
ALKA BOYED	Public	1.49%	—	—
BHAGWANTI HASTIMAL JAIN	Public	1.22%	—	—
SNEHPRABHA AGARWAL	Public	1.02%	—	—
VIMLA S SHARMA	Public	1.02%	—	—
SAVITRI NARESHCHANDRA JAIN	Public	1.02%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY (TTM)	Profit YoY (TTM)	1Y return
Sun Pharmaceutical Industries Ltd.	4,36,669	1,820.00	36.04	17.90%	+11.41%	+16.54%	+14.11%
Divi's Laboratories Ltd.	2,46,408	9,282.00	84.24	19.00%	+16.35%	+26.84%	+63.20%
Torrent Pharmaceuticals Ltd.	1,82,627	4,801.50	84.71	9.10%	+32.85%	+7.69%	+33.35%
Zydus Lifesciences Limited	1,16,045	1,163.35	25.27	19.20%	+21.11%	-2.51%	+18.50%
Cipla Ltd.	1,09,063	1,350.00	32.50	14.90%	+1.85%	-37.69%	-10.10%
Laurus Labs Limited	1,07,068	1,981.60	98.17	19.70%	+22.62%	+114.95%	+135.36%
Mankind Pharma Limited	1,03,468	2,505.00	50.04	13.70%	+13.75%	+8.10%	+2.79%
Dr. Reddy's Laboratories Ltd.	1,03,162	1,236.00	32.41	13.90%	-0.87%	-44.57%	+1.01%
Aurobindo Pharma Ltd.	95,887	1,666.50	25.84	13.60%	+9.09%	+9.48%	+53.76%
Lupin Ltd	93,379	2,042.00	16.82	28.40%	+28.19%	+49.13%	+6.90%
Glenmark Pharmaceuticals ltd	65,191	2,309.90	36.26	16.20%	+32.94%	+138.48%	+18.29%
Alkem Laboratories Limited	61,528	5,146.00	27.91	18.80%	+13.36%	-5.52%	-5.09%
Biocon Ltd.	60,462	371.00	145.20	2.90%	+9.83%	-36.60%	+8.85%
Abbott India Ltd. S	57,691	27,149.40	35.73	41.90%	+6.29%	+11.18%	-7.28%
Ipca Laboratories Ltd.	48,888	1,927.30	35.56	16.40%	+10.59%	+67.91%	+43.68%
Gland Pharma Limited	47,919	2,904.00	42.44	13.70%	+17.57%	+46.55%	+45.70%
GlaxoSmithkline Pharmaceuticals Ltd.	46,885	2,767.60	43.89	55.40%	+5.75%	+12.41%	+4.18%
Ajanta Pharma Ltd.	45,203	3,617.45	39.82	29.40%	+20.19%	+22.04%	+50.28%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87%	+7.56%	+45.79%
Emcure Pharmaceuticals Limited	36,846	1,942.20	36.15	25.10%	+18.36%	+32.39%	+51.75%
Wockhardt Ltd	34,374	2,115.50	83.03	6.40%	+18.37%	+377.85%	+39.72%
Sai Life Sciences Limited	32,411	1,526.00	89.55	18.10%	—	—	+77.29%
PIRAMAL PHARMA LIMITED	27,466	206.30	-87.58	0.80%	+0.78%	-419.79%	+8.07%
Neuland Laboratories Limited.	27,447	21,392.65	55.14	23.10%	+78.33%	+182.59%	+46.31%
ACUTAAS CHEMICALS LIMITED	26,847	3,279.15	69.31	27.70%	+40.91%	+104.14%	+148.65%
Triochem Products Ltd. S	0	—	0.05	50.80%	—	—	—

Filings & corporate actions

Recent announcements

Closure of Trading Window for the Quarter Ended 30-Sep-2630 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
We hereby submit the Annual Report for the FY 2025-26 duly approved and adopted by the members as per provision of the Companies Act, 2013, in the Annual General meeting of the Company ....24 Aug 2026 · Company Update / Meeting Updates
The voting results along with the Scrutinizer Report on thee resolution approved by the Shareholders at the Fifty Four Annual General Meeting of the Triochem Products Limited held on 22nd ....24 Aug 2026 · AGM/EGM / AGM
Summary of proceesings pf the AGM of the Compnay as required under Regualtion 30, read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosurer Requirements) Regualtion, ....22 Aug 2026 · AGM/EGM / AGM
Publication of Standalone Unaudited Financial Result for the Quarter Ended 30th June 2026 in Newspaper19 Aug 2026 · Company Update / Newspaper Publication
Not Applicable for the quarter ended 30th June 202614 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Unaudited Standalone Financial Result for the Quarter Ended 30th June 2026 approved in Board of Director Meeting held on 14th August 202614 Aug 2026 · Result / Financial Results
This is to inform you that, pursuant to Notice of Board meeting dated 8th August 2026 the Board Meeting of the Company was held today Friday 14th August 2026 at 3.00 p.m. at 4th Floor, ....14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Notice of Board Meeting Publice in New Paper10 Aug 2026 · Company Update / Newspaper Publication
Triochem Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1) Consider and approve the ....8 Aug 2026 · Board Meeting / Board Meeting
Notice of 54th Annual General Meeting Publice in New Paper31 Jul 2026 · Company Update / Newspaper Publication
The Fifty-Four Annual General Meeting (AGM) of the Company will be held on Saturday, 22nd August 2026 at 3.00 p.m. at Sambava Chambers, 4th Floor, Sir. P. M. Road, Fort, Mumbai: 400001. Pursuant ....30 Jul 2026 · Others / Reg. 34 (1) Annual Report
The Notice of Fifty Four Annual General Meeting (AGM) of the Company will be held on Saturday 22nd August 2026 at 3.00 p.m. at 4th Floor Sambava Chambers Sir P M Road Fort Mumbai 400001 The ....30 Jul 2026 · AGM/EGM / AGM
Confirmation Certificate dated 1st July 202615 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks ....15 Jul 2026 · Others / Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks / financial institutions.
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities15 Jul 2026 · Others / Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities.
Not Applicable as no such securities are issued by the Company15 Jul 2026 · Others / 57 (5) : intimation after the end of quarter
Not Applicable for the quarter ended 30-Jun-2026. The Company has not issued debt / non convertible securities30 Jun 2026 · Others / 57 (4) : Prior intimation to the beginning of the quarter
Closure of Trading Window for the quarter ended 30-Jun-202630 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Audited Financial Result for the quarter and year ended 31st March 2026 in newspaper1 Jun 2026 · Company Update / Newspaper Publication
The Board of Directors have decided that the Register of Members and the Share Transfer Register of the Company shall remain closed from Sunday 16th August 2026 to Saturday 22nd August ....29 May 2026 · Corp. Action / Book Closure
We hereby confirm that the Company has not raised / made offers by way of Public Issue, Rigth Issue, Preferential Issure, Qualified Institutions Placement (QIP), etc. therefore for the ....29 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
This is to inform you that disclosures of the Related Party Transaction on a consolidated basis under Regualtion 23(9) of SEBI (LODR) (Amendment) Regualtion 2018 is not applicable to our company..29 May 2026 · Company Update / General
This is to inform you that Annual Secretarial Compliance Report Under Regulartion 24A of SEBI (LODR) (Amendment) Regualtion 2018 read with BSE Circular dated 9th May 2019 is not applicable ....29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Audited Financial Results of the Company for the Quarter / Year Ended 31st March 2026 duly Reviewed by the Audi Committee along with Declaration is given in compliance to Regulation 30(3)(d) ....29 May 2026 · Result / Financial Results
We would like to inform you that, pursuant to Notice of Board meeting dated 22nd May 2026 the Board Meeting of the Company was held today Friday, 29th May 2026 at 3.00 p.m. at 4th Floor, ....29 May 2026 · Board Meeting / Outcome of Board Meeting
Notice of Board Meeting dated 22nd May 2026 in news paper25 May 2026 · Company Update / Newspaper Publication
Triochem Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1) To consider, approve ....22 May 2026 · Board Meeting / Board Meeting
Confirmation Certificate dated 3rd April 2026 issued by RTA16 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....16 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....16 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks ....16 Apr 2026 · Others / Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks / financial institutions.
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities16 Apr 2026 · Others / Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities.
Not Applicable as no such securities are issued by the Company16 Apr 2026 · Others / 57 (5) : intimation after the end of quarter
In pursuance to Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and terms of the provision of Section ....20 Mar 2026 · Board Meeting / Outcome of Board Meeting
CLosure of Trading Window for the Quarter Ended 31st March 202619 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
We confirm Nil report19 Mar 2026 · Others / 57 (4) : Prior intimation to the beginning of the quarter
Triochem Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 ,inter alia, to consider and approve Pursuant to the Regulation ....13 Mar 2026 · Board Meeting / Board Meeting
We would like to inform that the, there is typographical error in Limited Review Report for Standalone Financail Results for the Quarter Ended 31st December 2025 now corrected (wrong period ....23 Feb 2026 · Result / Financial Results
Unaudited Financial Result for the Quarter and Nine Month Ended 31-Dec-2514 Feb 2026 · Company Update / Newspaper Publication

Board meetings

14 Aug 2026 Board Meeting - Financial Results